123 related articles for article (PubMed ID: 12553000)
21. p63 in prostate biology and pathology.
Grisanzio C; Signoretti S
J Cell Biochem; 2008 Apr; 103(5):1354-68. PubMed ID: 17879953
[TBL] [Abstract][Full Text] [Related]
22. Ubiquitous p63 expression in human esophageal squamous cell carcinoma.
Hara T; Kijima H; Yamamoto S; Kenmochi T; Kise Y; Tanaka H; Chino O; Shimada H; Takazawa K; Tanaka M; Inokuchi S; Makuuchi H
Int J Mol Med; 2004 Aug; 14(2):169-73. PubMed ID: 15254760
[TBL] [Abstract][Full Text] [Related]
23. Progression of prostate cancer from a subset of p63-positive basal epithelial cells in FG/Tag transgenic mice.
Reiner T; de Las Pozas A; Parrondo R; Perez-Stable C
Mol Cancer Res; 2007 Nov; 5(11):1171-9. PubMed ID: 17982114
[TBL] [Abstract][Full Text] [Related]
24. Epithelial and prostatic marker expression in short-term primary cultures of human prostate tissue samples.
Festuccia C; Angelucci A; Gravina GL; Muzi P; Miano R; Vicentini C; Bologna M
Int J Oncol; 2005 May; 26(5):1353-62. PubMed ID: 15809728
[TBL] [Abstract][Full Text] [Related]
25. Dysregulated expression of S100A11 (calgizzarin) in prostate cancer and precursor lesions.
Rehman I; Azzouzi AR; Cross SS; Deloulme JC; Catto JW; Wylde N; Larre S; Champigneuille J; Hamdy FC
Hum Pathol; 2004 Nov; 35(11):1385-91. PubMed ID: 15668896
[TBL] [Abstract][Full Text] [Related]
26. DeltaNp63alpha and TAp63alpha regulate transcription of genes with distinct biological functions in cancer and development.
Wu G; Nomoto S; Hoque MO; Dracheva T; Osada M; Lee CC; Dong SM; Guo Z; Benoit N; Cohen Y; Rechthand P; Califano J; Moon CS; Ratovitski E; Jen J; Sidransky D; Trink B
Cancer Res; 2003 May; 63(10):2351-7. PubMed ID: 12750249
[TBL] [Abstract][Full Text] [Related]
27. Expression profiles of p63, p53, survivin, and hTERT in skin tumors.
Park HR; Min SK; Cho HD; Kim KH; Shin HS; Park YE
J Cutan Pathol; 2004 Sep; 31(8):544-9. PubMed ID: 15268709
[TBL] [Abstract][Full Text] [Related]
28. Expression of ezrin in prostatic intraepithelial neoplasia.
Pang ST; Fang X; Valdman A; Norstedt G; Pousette A; Egevad L; Ekman P
Urology; 2004 Mar; 63(3):609-12. PubMed ID: 15028477
[TBL] [Abstract][Full Text] [Related]
29. p63 gene expression study and early bladder carcinogenesis.
Compérat E; Bièche I; Dargère D; Ferlicot S; Laurendeau I; Benoît G; Vieillefond A; Verret C; Vidaud M; Capron F; Bedossa P; Paradis V
Urology; 2007 Sep; 70(3):459-62. PubMed ID: 17905096
[TBL] [Abstract][Full Text] [Related]
30. p63 expression in odontogenic cysts.
Lo Muzio L; Santarelli A; Caltabiano R; Rubini C; Pieramici T; Fior A; Trevisiol L; Carinci F; Leonardi R; Bufo P; Lanzafame S; Piattelli A
Int J Oral Maxillofac Surg; 2005 Sep; 34(6):668-73. PubMed ID: 16053892
[TBL] [Abstract][Full Text] [Related]
31. Distribution of p63, a novel myoepithelial marker, in fine-needle aspiration biopsies of the breast: an analysis of 82 samples.
Reis-Filho JS; Milanezi F; Amendoeira I; Albergaria A; Schmitt FC
Cancer; 2003 Jun; 99(3):172-9. PubMed ID: 12811858
[TBL] [Abstract][Full Text] [Related]
32. Basal cell cocktail (34betaE12 + p63) improves the detection of prostate basal cells.
Zhou M; Shah R; Shen R; Rubin MA
Am J Surg Pathol; 2003 Mar; 27(3):365-71. PubMed ID: 12604893
[TBL] [Abstract][Full Text] [Related]
33. Comparative study of p63 and p53 expression in tissue microarrays of malignant melanomas.
Brinck U; Ruschenburg I; Di Como CJ; Buschmann N; Betke H; Stachura J; Cordon-Cardo C; Korabiowska M
Int J Mol Med; 2002 Dec; 10(6):707-11. PubMed ID: 12429996
[TBL] [Abstract][Full Text] [Related]
34. p63 correlates with both BRCA1 and cytokeratin 5 in invasive breast carcinomas: further evidence for the pathogenesis of the basal phenotype of breast cancer.
Ribeiro-Silva A; Ramalho LN; Garcia SB; Brandão DF; Chahud F; Zucoloto S
Histopathology; 2005 Nov; 47(5):458-66. PubMed ID: 16241993
[TBL] [Abstract][Full Text] [Related]
35. Appearance of angiotensin II expression in non-basal epithelial cells is an early feature of malignant change in human prostate.
Louis SN; Wang L; Chow L; Rezmann LA; Imamura K; MacGregor DP; Casely D; Catt KJ; Frauman AG; Louis WJ
Cancer Detect Prev; 2007; 31(5):391-5. PubMed ID: 18031950
[TBL] [Abstract][Full Text] [Related]
36. p63: Molecular complexity in development and cancer.
Westfall MD; Pietenpol JA
Carcinogenesis; 2004 Jun; 25(6):857-64. PubMed ID: 15033906
[TBL] [Abstract][Full Text] [Related]
37. The transactivating isoforms of p63 are overexpressed in high-grade follicular lymphomas independent of the occurrence of p63 gene amplification.
Pruneri G; Fabris S; Dell'Orto P; Biasi MO; Valentini S; Del Curto B; Laszlo D; Cattaneo L; Fasani R; Rossini L; Manzotti M; Bertolini F; Martinelli G; Neri A; Viale G
J Pathol; 2005 Jul; 206(3):337-45. PubMed ID: 15887287
[TBL] [Abstract][Full Text] [Related]
38. INSL3 in the benign hyperplastic and neoplastic human prostate gland.
Klonisch T; Müller-Huesmann H; Riedel M; Kehlen A; Bialek J; Radestock Y; Holzhausen HJ; Steger K; Ludwig M; Weidner W; Hoang-Vu C; Hombach-Klonisch S
Int J Oncol; 2005 Aug; 27(2):307-15. PubMed ID: 16010410
[TBL] [Abstract][Full Text] [Related]
39. p63 is a prostate basal cell marker and is required for prostate development.
Signoretti S; Waltregny D; Dilks J; Isaac B; Lin D; Garraway L; Yang A; Montironi R; McKeon F; Loda M
Am J Pathol; 2000 Dec; 157(6):1769-75. PubMed ID: 11106548
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical antibody cocktail staining (p63/HMWCK/AMACR) of ductal adenocarcinoma and Gleason pattern 4 cribriform and noncribriform acinar adenocarcinomas of the prostate.
Herawi M; Epstein JI
Am J Surg Pathol; 2007 Jun; 31(6):889-94. PubMed ID: 17527076
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
